期刊文献+

Ⅳ期乳腺癌局部区域治疗的研究进展 被引量:7

Progress of stage-Ⅳ breast cancer treated with local-regional therapy
原文传递
导出
摘要 目的:探讨Ⅳ期乳腺癌局部-区域治疗的方法、意义及对患者生存期的影响。方法:应用PubMed、CNKI及万方期刊全文数据库检索系统,以"乳腺肿瘤、Ⅳ期"和"局部治疗"或"区域治疗"等为关键词,检索2000-01-2012-10的相关文献。纳入标准:1)Ⅳ期乳腺癌局部-区域治疗的预后;2)Ⅳ期乳腺癌局部-区域治疗的措施及意义。根据纳入的标准,精选39篇文献进行分析。结果:Ⅳ期乳腺癌的局部-区域治疗可提高乳腺癌患者的中位生存时间;局部-区域治疗主要是通过手术或者局部放疗及两者联合的治疗方法来根治原发病灶,或减小肿瘤负荷、获得更详细的临床病理资料,同时局部治疗的介入也使综合治疗的顺应性更好,在一定程度上减轻患者的心理负担。结论:Ⅳ期乳腺癌在全身治疗的基础上,局部-区域治疗适时、适度的介入,是延长Ⅳ期乳腺癌患者的生存时间,改善患者的生活质量有效的治疗措施之一。 OBJECTIVE: To review the literature and evaluate the relation between local-regional therapy and the pa- tients survival rate in stage- breast cancer. METHODS: Using breast cancer, stage-.IV , local therapy and regional thera- py as keywords to retrieve 2000-01--2012-10 related papers on PubMed,CNKI and Wangfang database system. Criteri- on: 1) The prognosis of stage-iV breast cancer with local-regional therapy. 2) The measures and significance of stage- breast cancer with local-regional therapy. Thirty-nine literatures were selected to summarize. RESULTS: Large number of previous studies have demonstrated that local-therapy is a positive factor to improve survival in patients with stage-IV breast cancer. This treatment is mainly through the surgery or local radiotherapy to cure primary lesions and could can minimize the tumor load,get more clinical and pathological details. At the same time the intervention of local-regional ther- apy also makes comprehensive treatment adaptable and the psychological burden alleviatable for patients. CONCLUSION: It is a efficient measure to improve the patients' quality of life and to extend survival rate of stage- breast cancer when lo- cal-regional therapy appropriately applied on the basement of systemic threapy.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第5期396-400,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 Ⅳ期乳腺癌 局部一区域治疗 中位生存时间 综述文献 Stage-IV breast cancer Local-regional therapySurvival rate review literture
  • 相关文献

参考文献46

  • 1Sant M,Allemani C,Berrino F,et al. Breast carcinoma survival in Europe and the United States[J]. Cancer, 2004, 100 (4) : 715- 722.
  • 2Goldhirsch A, Wood WC,Gelber RD, et al. Progress and prom- ise:highlights of the international expert consensus on the pri- mary therapy of early breast eancer2007[J]. Ann Oncol, 2007,18 (7) :1133-1144.
  • 3Noguch M,Nakano Y, Noguchi M, et al. Local therapy and sur- vival in breast cancer with distant metastases[J]. J Surg Oneol, 2011,105(1) :104-110.
  • 4Wood WC, Muss HB, Solin LJ,et al. Malignant tumors of the breast[M]//DeVita VT Jr, Hellman S, Rosenberg SA. Cancer principles and practice of oncology. 7th edn. Lippincott Williams, Philadelphia, 2005 : 1415-1478.
  • 5Neuman HB, Morrogh M,Gonen M, et al. Stage IV breast cancer in the era of targeted therapy:does surgery of the primary tumor matter? [J]. Cancer,2010,116(5) :1226-1233.
  • 6Sofi AA,Mohamed I, Koumaya M, et al. Local therapy in meta- static breast cancer is associated with improved survival [J]. Am J Ther,2011(4)[Epub ahead of print].
  • 7Amar S,Roy V,Perez EA. Treatment of metastatic breast cane- er:looking towards the future [J]. Breast Cancer Res Treat, 2009,114(3) :413-422.
  • 8Babiera GV,Rao R,Feng L,et al. Effect of primary tumor extir-pation in breast cancer patients who present with stage IV dis- ease and an intact primary tumor [J]. Ann Surg Oncol, 2006,13 (6) :776-782.
  • 9Wood WC, Muss HB, Solin LJ, et al. Malignant tumors of the breast[M]// DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology, 7th edn. Lippincott Williams, Philadelphia, 2005 : 1415-1478.
  • 10傅军民.影响转移性乳腺癌预后相关因素分析[J].河北医科大学学报,2011,32(12):1408-1410. 被引量:2

二级参考文献166

共引文献85

同被引文献78

  • 1李艳,尹立雪,李文华.经皮超声造影检测兔 VX2乳腺癌前哨淋巴结的实验研究[J].中华医学超声杂志(电子版),2013,10(5):420-426. 被引量:12
  • 2洪卫,冉立,卢冰,杨黎,常建英,甘家应,胡银祥.乳腺癌改良根治术后放疗降低患侧肺受量的剂量学研究[J].中华放射医学与防护杂志,2011,31(6). 被引量:17
  • 3Siegel R. Naishadham D.Jemal A. Global cancer sta tistics v Zu l S[J]. CA CancerJ Clin.2013.63(1) :11-30.
  • 4Freedman GM. Anderson PR. Bleicheer RJ. Five year local control in a phase IT study of hypofractionated intensity modula ted radiation therapy with an incorporated boost for early stage breast cancer[J]. IntJ Radiat Oncol Biol Phys , 2012. (4): 888-893.
  • 5Hardee ME. Raza S. Becker SJ. et al. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique[J]. IntJ Radiat Oncol BioI Phys , 2012.82(3): 415-423.
  • 6Sethi RA. No HS.Jozsef G. et al. Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level ill and supraclavicular nodes in a prone versus supine position[J]. Radiother Oncol.2012.102(1) :74-81.
  • 7Ning ZH. MuJM.JinJX. et al. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy[J]. Radiother Oncol , 2013.8: 237-246.
  • 8Beckham WA. Popescu CC. Patenaude VV. et al. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?[J]. IntJ Radiat Oncol Biol Phys , 2007. 69(3) : 918-924.
  • 9Taylor CW.McGale P.PovallJM. et al. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice[J]. IntJ Radiat Oncol Bioi Phys.2009.3(4) :1061-1068.
  • 10Recht A. Ancukiewicz M. EI-Din MAA. et al. Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy[J].J Clin Oncol , 2009. 27 ( 24 ) : 3887-3893.

引证文献7

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部